Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · IEX Real-Time Price · USD
1.225
-0.035 (-2.78%)
At close: Jul 19, 2024, 12:00 AM
1.240
+0.015 (1.22%)
Pre-market: Jul 22, 2024, 9:16 AM EDT
Seres Therapeutics Employees
Seres Therapeutics had 233 employees as of December 31, 2023. The number of employees decreased by 198 or -45.94% compared to the previous year.
Employees
233
Change (1Y)
-198
Growth (1Y)
-45.94%
Revenue / Employee
$544,408
Profits / Employee
-$354,863
Market Cap
185.52M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Coherus BioSciences | 306 |
908 Devices | 230 |
Inhibrx | 172 |
OptimizeRx | 136 |
Biomea Fusion | 103 |
Fractyl Health | 94 |
XBiotech | 82 |
Candel Therapeutics | 42 |
MCRB News
- 6 weeks ago - Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023 - PRNewsWire
- 6 weeks ago - Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science - GlobeNewsWire
- 2 months ago - Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates - Business Wire
- 2 months ago - Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024 - Business Wire
- 3 months ago - Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT - Business Wire
- 3 months ago - VKTX, JANX and these biotech stocks are surging in 2024 - Invezz
- 4 months ago - Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates - Business Wire